Please login to the form below

Not currently logged in
Email:
Password:

Arthritis patient group launches interactive video initiative

NRAS hopes its Love Your Heart programme will lower CV risks in those with RA

NRAS Love Your Heart RA CVD Streaming Well

A UK arthritis patient group has launched an interactive video programme that it hopes will help lower cardiovascular risks in people with rheumatoid arthritis (RA).

NRAS’ Love Your Heart educational initiative went live this week on Valentine’s Day to raise awareness of the increased risk of cardiovascular disease (CVD) for those with RA.

More than 400,000 people have RA in the UK, but NRAS says it lacks the public awareness of Parkinson’s (which affects 127,000) or multiple sclerosis (100,000).

Founder and CEO Ailsa Bosworth said: “It is still a relatively misunderstood and invisible disease. Getting to a diagnosis can therefore often be challenging as people don’t recognise the symptoms as a medical emergency.

“Equally, the increased risk of CVD is relatively unknown and… [I] hope that the Love your Heart programme will help all those with RA, like myself, to lead a longer and healthier life by addressing those risk factors that are within our own control.”

The free online video programme, which was developed by NRAS, consultant rheumatologist Dr Holly John and interactive video producer Streaming Well, covers areas such as the reasons why RA increases CVD risk and how to calculate the GP-recognised prediction algorithm QRISK2.

Streaming Well CEO Francis Namouk said: “I believe that this initiative is the first of its kind within healthcare in that it incorporates a full training programme into a single interactive video. Originally, the programme was to be launched as a website, but we realised that increasing the amount of video and making it interactive would bolster the learning outcomes for patients.”

The data from the programme will help rheumatologists and GPs, with NRAS hoping it will become a referral platform for when people are diagnosed.

Article by
Dominic Tyer

15th February 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics